U.S. Physical Therapy (USPH) Announces Quarterly Earnings Results, Beats Estimates By $0.05 EPS
U.S. Physical Therapy (NASDAQ:USPH) posted its quarterly earnings results on Thursday. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.30 by $0.05, Stock Ratings Network.com reports. The company had revenue of $62.80 million for the quarter, compared to the consensus estimate of $67.70 million. During the same quarter in the previous year, the company posted $0.31 earnings per share. The company’s revenue for the quarter was up 11.1% on a year-over-year basis.
USPH has been the subject of a number of recent research reports. Analysts at Jefferies Group raised their price target on shares of U.S. Physical Therapy from $34.00 to $38.00 in a research note on Thursday, April 10th. They now have a “buy” rating on the stock. Analysts at Stephens initiated coverage on shares of U.S. Physical Therapy in a research note on Thursday, March 27th. They set an “overweight” rating and a $40.00 price target on the stock. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $36.27.
U.S. Physical Therapy (NASDAQ:USPH) traded up 1.98% on Thursday, hitting $30.95. 1,220 shares of the company’s stock traded hands. U.S. Physical Therapy has a one year low of $23.94 and a one year high of $37.25. The stock has a 50-day moving average of $32.64 and a 200-day moving average of $32.88. The company’s market cap is $377.5 million.
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.